Used as a key intermediate in the synthesis of pharmaceutical peptides, particularly in the production of protease inhibitors. Its chiral center and protected amine group make it valuable in solid-phase peptide synthesis, where it helps maintain stereochemical integrity during coupling reactions. The fluorenylmethyloxycarbonyl (Fmoc) group allows for mild deprotection conditions, compatible with sensitive peptide sequences. Commonly employed in the development of antihypertensive and antiviral agents due to the structural similarity with phenylalanine derivatives. Also utilized in research settings for creating peptide-based probes and enzyme substrates.